{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:55:54Z","timestamp":1777492554210,"version":"3.51.4"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Ocular inflammation is a common complication of various eye diseases with wide consequences from irritations to potentially sight-threatening complications. Green tea is a popular beverage throughout the world. One of the proven health benefits of consuming green tea extract (GTE) is anti-inflammation. Catechins are the biologically active constituents of GTE. In<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>studies, GTE and catechins present inhibition of inflammatory responses in the development of ocular inflammation including infectious, non-infectious or autoimmune, and oxidative-induced complications. Research on the ocular inflammation in animal models has made significant progress in the past decades and several key disease mechanisms have been identified. Here we review the experimental investigations on the effects of GTE and catechins on various ocular inflammation related diseases including glaucoma, age-related macular degeneration, uveitis and ocular surface inflammation. We also review the pharmacokinetics of GTE constituents and safety of green tea consumption. We discuss the insights and perspectives of these experimental results, which would be useful for future development of novel therapeutics in human.<\/jats:p>","DOI":"10.3389\/fnut.2021.753955","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:09:09Z","timestamp":1639415349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-inflammatory Effects of GTE in Eye Diseases"],"prefix":"10.3389","volume":"8","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai On","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmos Liutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy Oi Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Kit","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"c4976","DOI":"10.1136\/bmj.c4976","article-title":"Investigation and management of uveitis","volume":"341","author":"Guly","year":"2010","journal-title":"BMJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"Am J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iio.0000155938.83083.94","article-title":"Epidemiology of uveitis","volume":"45","author":"Wakefield","year":"2005","journal-title":"Int Ophthalmol Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0b013e31829f7415","article-title":"The roles of genetic factors in uveitis and their clinical significance","volume":"34","author":"Yang","year":"2014","journal-title":"Retina."},{"key":"B7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/postgradmedj-2017-134891","article-title":"Uveitis: a sight-threatening disease which can impact all systems","volume":"93","author":"Krishna","year":"2017","journal-title":"Postgrad Med J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: the corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs."},{"key":"B9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jfo.2019.03.033","volume":"43","author":"Couret","year":"2020","journal-title":"J Fr Ophtalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/ICU.0000000000000562","article-title":"Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics","volume":"30","author":"Thomas","year":"2019","journal-title":"Curr Opin Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1749-6632.1993.tb17166.x","article-title":"Treatment of autoimmune uveitis","volume":"696","author":"Whitcup","year":"1993","journal-title":"Ann N Y Acad Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/14728214.2011.537824","article-title":"Emerging drugs for uveitis","volume":"16","author":"Larson","year":"2011","journal-title":"Expert Opin Emerg Drugs."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3760\/cma.j.issn.0366-6999.20123565","article-title":"Neuroprotection in glaucoma: present and future","volume":"126","author":"Chen","year":"2013","journal-title":"Chin Med J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in glaucoma: a new opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp Eye Res."},{"key":"B16","first-page":"2282","article-title":"Sustained stress response after oxidative stress in trabecular meshwork cells","volume":"13","author":"Li","year":"2007","journal-title":"Mol Vis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"32722","DOI":"10.1074\/jbc.271.51.32722","article-title":"Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures","volume":"271","author":"Kolko","year":"1996","journal-title":"J Biol Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm1362","article-title":"Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity","volume":"12","author":"Kawano","year":"2006","journal-title":"Nat Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12031-010-9343-z","article-title":"Hypoxia inducible factor-1alpha (HIF-1alpha) and some HIF-1 target genes are elevated in experimental glaucoma","volume":"42","author":"Ergorul","year":"2010","journal-title":"J Mol Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jnr.24256","article-title":"Neuroinflammation and microglia in glaucoma: time for a paradigm shift","volume":"97","author":"Wei","year":"2019","journal-title":"J Neurosci Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/glia.22507","article-title":"Reversible reactivity by optic nerve astrocytes","volume":"61","author":"Sun","year":"2013","journal-title":"Glia."},{"key":"B22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3904\/kjim.2014.29.1.1","article-title":"Antiangiogenesis therapy: an update after the first decade","volume":"29","author":"De Falco","year":"2014","journal-title":"Korean J Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Group","year":"2011","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm.2717","article-title":"NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components","volume":"18","author":"Doyle","year":"2012","journal-title":"Nat Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e67263","DOI":"10.1371\/journal.pone.0067263","article-title":"A2E induces IL-1ss production in retinal pigment epithelial cells via the NLRP3 inflammasome","volume":"8","author":"Anderson","year":"2013","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exer.2013.04.016","article-title":"Complement expression in retinal pigment epithelial cells is modulated by activated macrophages","volume":"112","author":"Luo","year":"2013","journal-title":"Exp Eye Res."},{"key":"B32","first-page":"1253","article-title":"Complement factor I and age-related macular degeneration","volume":"20","author":"Alexander","year":"2014","journal-title":"Mol Vis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","year":"2007","journal-title":"Ocul Surf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/ICL.0000000000000640","article-title":"The effect of ocular demodex colonization on schirmer test and OSDI scores in newly diagnosed dry eye patients","volume":"46","author":"Ayyildiz","year":"2020","journal-title":"Eye Contact Lens."},{"key":"B36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/genes12030365","article-title":"Ophthalmologic manifestations of primary sjogren's syndrome","volume":"12","author":"Roszkowska","year":"2021","journal-title":"Genes."},{"key":"B37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1442-9071.2012.02781.x","article-title":"Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication","volume":"40","author":"Ghosh","year":"2012","journal-title":"Clin Exp Ophthalmol."},{"key":"B38","first-page":"675","article-title":"[Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients]","volume":"26","author":"Pisella","year":"2003","journal-title":"J Fr Ophtalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4155\/cli.14.135","article-title":"Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence","volume":"5","author":"Ames","year":"2015","journal-title":"Clin Investig."},{"key":"B40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf."},{"key":"B41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.phrs.2011.03.018","article-title":"Tea catechins and their applications as supplements and pharmaceutics","volume":"64","author":"Hara","year":"2011","journal-title":"Pharmacol Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/01635581.2012.630158","article-title":"New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer","volume":"64","author":"Connors","year":"2012","journal-title":"Nutr Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/jhn.12408","article-title":"Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women","volume":"30","author":"Dostal","year":"2017","journal-title":"J Hum Nutr Diet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000480636","article-title":"Sulforaphane and epigallocatechin gallate restore estrogen receptor expression by modulating epigenetic events in the breast cancer cell line MDA-MB-231: a systematic review and meta-analysis","volume":"10","author":"Gianfredi","year":"2017","journal-title":"J Nutrigenet Nutrigenomics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jchromb.2006.02.008","article-title":"Determination of green tea catechins in human plasma using liquid chromatography-electrospray ionization mass spectrometry","volume":"834","author":"Masukawa","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jff.2013.08.011","article-title":"Green tea extract: chemistry, antioxidant properties and food applications \u2013 a review","volume":"5","author":"Namal Senanayake","year":"2013","journal-title":"J Func Foods."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1021\/acs.jafc.8b06146","article-title":"Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols","volume":"67","author":"Xing","year":"2019","journal-title":"J Agric Food Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1021\/jf9032602","article-title":"Green tea catechins and their oxidative protection in the rat eye","volume":"58","author":"Chu","year":"2010","journal-title":"J Agric Food Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jnutbio.2015.07.001","article-title":"Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues","volume":"26","author":"Chu","year":"2015","journal-title":"J Nutr Biochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/humrep\/del353","article-title":"Uptake and distribution of catechins in fetal organs following in utero exposure in rats","volume":"22","author":"Chu","year":"2007","journal-title":"Hum Reprod."},{"key":"B51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-5728(93)90028-W","article-title":"Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis","volume":"47","author":"Caspi","year":"1993","journal-title":"J Neuroimmunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/intimm\/dxh158","article-title":"The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS","volume":"16","author":"Thurau","year":"2004","journal-title":"Int Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J Clin Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1167\/iovs.17-22436","article-title":"Quantitative characterization of autoimmune uveoretinitis in an experimental mouse model","volume":"58","author":"Li","year":"2017","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41598-019-38868-1","article-title":"Green tea catechins alleviate autoimmune symptoms and visual impairment in a murine model for human chronic intraocular inflammation by inhibiting Th17-associated pro-inflammatory gene expression","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1167\/iovs.10-6909","article-title":"Understanding autoimmune uveitis through animal models. The Friedenwald Lecture","volume":"52","author":"Caspi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J Interferon Cytokine Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/0192-0561(88)90486-9","article-title":"IL-6\/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells","volume":"141","author":"Okada","year":"1988","journal-title":"J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","article-title":"Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities","volume":"26","author":"Scheller","year":"2014","journal-title":"Semin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.intimp.2014.06.041","article-title":"Interleukin-1beta promotes the induction of retinal autoimmune disease","volume":"22","author":"Zhao","year":"2014","journal-title":"Int Immunopharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2017.02.023","article-title":"Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice","volume":"96","author":"Tode","year":"2017","journal-title":"Cytokine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cei.12295","article-title":"Interleukin-6 blockade in ocular inflammatory diseases","volume":"176","author":"Mesquida","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e103995","DOI":"10.1371\/journal.pone.0103995","article-title":"Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis","volume":"9","author":"Qin","year":"2014","journal-title":"PLoS ONE."},{"key":"B64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-9167-9_14","article-title":"Endotoxin-induced uveitis in rodents","volume":"1960","author":"Yadav","year":"2019","journal-title":"Methods Mol Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science."},{"key":"B66","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2006.09.067","article-title":"Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate","volume":"1124","author":"Zhang","year":"2006","journal-title":"Brain Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"7432797","DOI":"10.1155\/2016\/7432797","article-title":"Oxidative stress and inflammation: what polyphenols can do for us?","volume":"2016","author":"Hussain","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"29546","DOI":"10.1038\/srep29546","article-title":"Green tea catechins are potent anti-oxidants that ameliorate sodium iodate-induced retinal degeneration in rats","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"109606","DOI":"10.1016\/j.biopha.2019.109606","article-title":"Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1alpha\/VEGF\/VEGFR2 pathway and M1 type macrophage\/microglia polarization","volume":"121","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/jf000877h","article-title":"Degradation of green tea catechins in tea drinks","volume":"49","author":"Chen","year":"2001","journal-title":"J Agric Food Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10456-012-9299-4","article-title":"Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice","volume":"16","author":"Wang","year":"2013","journal-title":"Angiogenesis."},{"key":"B72","first-page":"171","article-title":"Intraperitoneal injection of (-)-Epigallocatechin-3-gallate protects against light-induced photoreceptor degeneration in the mouse retina","volume":"23","author":"Qi","year":"2017","journal-title":"Mol Vis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"12866","DOI":"10.1021\/acs.jafc.8b05998","article-title":"Metabolomics of green-tea catechins on vascular-endothelial-growth-factor-stimulated human-endothelial-cell survival","volume":"66","author":"Chu","year":"2018","journal-title":"J Agric Food Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ijbiomac.2018.04.011","article-title":"A polysaccharide from green tea (Camellia sinensis L.) protects human retinal endothelial cells against hydrogen peroxide-induced oxidative injury and apoptosis","volume":"115","author":"Yan","year":"2018","journal-title":"Int J Biol Macromol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cge.12203","article-title":"Genes and mutations causing retinitis pigmentosa","volume":"84","author":"Daiger","year":"2013","journal-title":"Clin Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exer.2017.10.023","article-title":"Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration","volume":"167","author":"LaVail","year":"2018","journal-title":"Exp Eye Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/antiox9080718","article-title":"Epigallocatechin gallate slows retinal degeneration, reduces oxidative damage, and modifies circadian rhythms in P23H rats","volume":"9","author":"Perdices","year":"2020","journal-title":"Antioxidants."},{"key":"B78","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4239\/wjd.v6.i5.726","article-title":"Functions of Muller cell-derived vascular endothelial growth factor in diabetic retinopathy","volume":"6","author":"Wang","year":"2015","journal-title":"World J Diabetes."},{"key":"B79","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yexcr.2019.04.014","article-title":"Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in retinal Muller cells under high-glucose conditions","volume":"380","author":"Wang","year":"2019","journal-title":"Exp Cell Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1860452","DOI":"10.1155\/2020\/1860452","article-title":"Long-term tea consumption is associated with reduced risk of diabetic retinopathy: a cross-sectional survey among elderly chinese from rural communities","volume":"2020","author":"Xu","year":"2020","journal-title":"J Diabetes Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"554","DOI":"10.7326\/0003-4819-144-8-200604180-00005","article-title":"The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults","volume":"144","author":"Iso","year":"2006","journal-title":"Ann Intern Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"412379","DOI":"10.1155\/2013\/412379","article-title":"Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications","volume":"2013","author":"Toolsee","year":"2013","journal-title":"Biomed Res Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.phymed.2015.12.013","article-title":"Bioactive compounds isolated from apple, tea, and ginger protect against dicarbonyl induced stress in cultured human retinal epithelial cells","volume":"23","author":"Sampath","year":"2016","journal-title":"Phytomedicine."},{"key":"B84","first-page":"323","article-title":"The global impact of glaucoma","volume":"72","author":"Thylefors","year":"1994","journal-title":"Bull World Health Organ."},{"key":"B85","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ajo.2004.04.054","article-title":"Risk assessment in the management of patients with ocular hypertension","volume":"138","author":"Weinreb","year":"2004","journal-title":"Am J Ophthalmol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","year":"2000","journal-title":"Am J Ophthalmol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1167\/iovs.10-5407","article-title":"Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling","volume":"51","author":"Luo","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e17659","DOI":"10.1371\/journal.pone.0017659","article-title":"Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death","volume":"6","author":"Gregory","year":"2011","journal-title":"PLoS ONE."},{"key":"B89","doi-asserted-by":"publisher","first-page":"12088","DOI":"10.1523\/JNEUROSCI.1273-15.2015","article-title":"Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation","volume":"35","author":"Cueva Vargas","year":"2015","journal-title":"J Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1167\/iovs.13-12941","article-title":"Clusterin and complement activation in exfoliation glaucoma","volume":"55","author":"Doudevski","year":"2014","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2014.07.016","article-title":"Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma","volume":"71","author":"Howell","year":"2014","journal-title":"Neurobiol Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9394(00)00862-X","article-title":"T cell subsets and sIL-2R\/IL-2 levels in patients with glaucoma","volume":"131","author":"Yang","year":"2001","journal-title":"Am J Ophthalmol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/02713683.2013.836541","article-title":"From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma","volume":"39","author":"Krizaj","year":"2014","journal-title":"Curr Eye Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00417-015-3168-y","article-title":"The effect of flavonoids on visual function in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis","volume":"253","author":"Patel","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"8407206","DOI":"10.1155\/2019\/8407206","article-title":"Green tea extract ameliorates ischemia-induced retinal ganglion cell degeneration in rats","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid Med Cell Longev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/dvdy.24406","article-title":"EGCG stabilizes growth cone filopodia and impairs retinal ganglion cell axon guidance","volume":"245","author":"Atkinson-Leadbeater","year":"2016","journal-title":"Dev Dyn."},{"key":"B97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2015.06.002","article-title":"Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma","volume":"600","author":"Shen","year":"2015","journal-title":"Neurosci Lett."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00417-009-1064-z","article-title":"Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram","volume":"247","author":"Falsini","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"Am J Ophthalmol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1167\/iovs.07-0002","article-title":"Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL\/6 mice: effects of desiccating stress","volume":"48","author":"Yoon","year":"2007","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1001\/archopht.126.12.1695","article-title":"Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease","volume":"126","author":"Ecoiffier","year":"2008","journal-title":"Arch Ophthalmol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/archophthalmol.2009.125","article-title":"Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2","volume":"127","author":"Goyal","year":"2009","journal-title":"Arch Ophthalmol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.lfs.2008.08.011","article-title":"Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease","volume":"83","author":"Gillespie","year":"2008","journal-title":"Life Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.2147\/IJN.S173198","article-title":"Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief","volume":"13","author":"Huang","year":"2018","journal-title":"Int J Nanomedicine."},{"key":"B107","first-page":"533","article-title":"Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells","volume":"17","author":"Cavet","year":"2011","journal-title":"Mol Vis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"NC05","DOI":"10.7860\/JCDR\/2017\/23336.9426","article-title":"Efficacy of green tea extract for treatment of dry eye and meibomian gland dysfunction; a double-blind randomized controlled clinical trial study","volume":"11","author":"Nejabat","year":"2017","journal-title":"J Clin Diagn Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0021-5155(97)00009-9","article-title":"Detection of interleukin-1 beta in the tear fluid of patients with corneal disease with or without conjunctival involvement","volume":"41","author":"Fukuda","year":"1997","journal-title":"Jpn J Ophthalmol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1167\/iovs.19-27306","article-title":"Inhibition by epigallocatechin gallate of IL-1-induced urokinase-type plasminogen activator expression and collagen degradation by corneal fibroblasts","volume":"60","author":"Sugioka","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B111","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0027-5107(85)90109-5","article-title":"Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor","volume":"150","author":"Kada","year":"1985","journal-title":"Mutat Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2007.05.029","article-title":"Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia\/reperfusion","volume":"1159","author":"Zhang","year":"2007","journal-title":"Brain Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br J Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/jn\/131.7.2034","article-title":"Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity","volume":"131","author":"Varilek","year":"2001","journal-title":"J Nutr."},{"key":"B116","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejphar.2007.10.053","article-title":"Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis","volume":"579","author":"Abboud","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1073\/pnas.96.8.4524","article-title":"Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea","volume":"96","author":"Haqqi","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B118","doi-asserted-by":"publisher","first-page":"14692","DOI":"10.1073\/pnas.0802675105","article-title":"Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production","volume":"105","author":"Ahmed","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3945\/jn.108.089912","article-title":"Green tea protects rats against autoimmune arthritis by modulating disease-related immune events","volume":"138","author":"Kim","year":"2008","journal-title":"J Nutr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/rheumatology\/kep397","article-title":"Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis","volume":"49","author":"Marotte","year":"2010","journal-title":"Rheumatology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1017\/S0007114510004824","article-title":"Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice","volume":"105","author":"Fu","year":"2011","journal-title":"Br J Nutr."},{"key":"B123","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/08916930601167343","article-title":"Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity","volume":"40","author":"Hsu","year":"2007","journal-title":"Autoimmunity."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3945\/jn.110.124743","article-title":"Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression","volume":"140","author":"Pae","year":"2010","journal-title":"J Nutr."},{"key":"B125","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajpath.2011.09.007","article-title":"Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets","volume":"180","author":"Wang","year":"2012","journal-title":"Am J Pathol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1676S","DOI":"10.3945\/ajcn.113.058271","article-title":"Cancer prevention by green tea: evidence from epidemiologic studies","volume":"98","author":"Yuan","year":"2013","journal-title":"Am J Clin Nutr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrurol.2014.42","article-title":"Prostate cancer in Asian men","volume":"11","author":"Ito","year":"2014","journal-title":"Nat Rev Urol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","article-title":"Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study","volume":"66","author":"Bettuzzi","year":"2006","journal-title":"Cancer Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1055-9965.EPI-06-0365","article-title":"Effects of repeated green tea catechin administration on human cytochrome P450 activity","volume":"15","author":"Chow","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.3390\/ijms20246196","article-title":"Health functions and related molecular mechanisms of tea components: an update review","volume":"20","author":"Tang","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ejcn.2016.165","article-title":"Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials","volume":"70","author":"Isomura","year":"2016","journal-title":"Eur J Clin Nutr."},{"key":"B132","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/1940-6207.CAPR-17-0160","article-title":"Effect of green tea supplements on liver enzyme elevation: results from a randomized intervention study in the United States","volume":"10","author":"Yu","year":"2017","journal-title":"Cancer Prev Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul Toxicol Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","article-title":"Hepatotoxicity from green tea: a review of the literature and two unpublished cases","volume":"65","author":"Mazzanti","year":"2009","journal-title":"Eur J Clin Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem Toxicol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","article-title":"Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice","volume":"48","author":"Lambert","year":"2010","journal-title":"Food Chem Toxicol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-04-2549","article-title":"Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals","volume":"11","author":"Chow","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/carcin\/19.12.2201","article-title":"(-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity","volume":"19","author":"Barthelman","year":"1998","journal-title":"Carcinogenesis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/s0006-2952(01)00767-5","article-title":"Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues","volume":"62","author":"Hong","year":"2001","journal-title":"Biochem Pharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1054\/bjoc.2000.1691","article-title":"EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells","volume":"84","author":"Jung","year":"2001","journal-title":"Br J Cancer."},{"key":"B141","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3177\/jnsv.43.679","article-title":"Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat","volume":"43","author":"Nakagawa","year":"1997","journal-title":"J Nutr Sci Vitaminol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"H47","DOI":"10.1111\/j.1750-3841.2008.01033.x","article-title":"Stability of green tea catechins in commercial tea leaves during storage for 6 months","volume":"74","author":"Friedman","year":"2009","journal-title":"J Food Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"110186","DOI":"10.1016\/j.foodres.2021.110186","article-title":"Opportunities and challenges for the nanodelivery of green tea catechins in functional foods","volume":"142","author":"Rashidinejad","year":"2021","journal-title":"Food Res Int."},{"key":"B144","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/1389450118666170508095250","article-title":"Nano-phytosome: a developing platform for herbal anti-cancer agents in cancer therapy","volume":"19","author":"Babazadeh","year":"2018","journal-title":"Curr Drug Targets."},{"key":"B145","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2010.06.010","article-title":"Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate","volume":"41","author":"Dube","year":"2010","journal-title":"Eur J Pharm Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.carbpol.2012.03.015","article-title":"Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate","volume":"89","author":"Hu","year":"2012","journal-title":"Carbohydr Polym."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1039\/c3fo60343a","article-title":"Bioefficacy of tea catechins encapsulated in casein micelles tested on a normal mouse cell line (4D\/WT) and its cancerous counterpart (D\/v-src) before and after in vitro digestion","volume":"5","author":"Haratifar","year":"2014","journal-title":"Food Funct."},{"key":"B148","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/biof.1171","article-title":"Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation","volume":"40","author":"Stefani","year":"2014","journal-title":"Biofactors."},{"key":"B149","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ajcn\/83.2.355","article-title":"Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1","volume":"83","author":"Kuriyama","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e96013","DOI":"10.1371\/journal.pone.0096013","article-title":"Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline","volume":"9","author":"Noguchi-Shinohara","year":"2014","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.753955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T09:40:12Z","timestamp":1726306812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.753955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":150,"alternative-id":["10.3389\/fnut.2021.753955"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.753955","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]},"article-number":"753955"}}